Inclusion Criteria:  Patient understands the procedures and requirements and is willing and able to give informed consent for full participation in the study. Previously healthy adults, male or female, aged 18 to 50 years at time of consent with early symptomatic COVID-19 SARS-CoV-2 positive by lateral flow antigen test Symptoms of COVID-19 (including fever, or history of fever) for less than 4 days (96 hours). Oxygen saturation ≥96% measured by pulse-oximetry at time of screening. Able to walk unaided and unimpeded in ADLs Agrees and is able to adhere to all study procedures, including availability and contact information for follow-up visits  Exclusion Criteria:  The patient may not enter the study if ANY of the following apply:  Taking any concomitant medications or drugs (see appendix 4)† Presence of any chronic illness/ condition requiring long term treatment, or other significant comorbidity (e.g. diabetes, obesity but see appendix 4 for the full list) Laboratory abnormalities discovered at screening (see appendix 4) For females: pregnancy, actively trying to become pregnant, or lactation Contraindication to taking, or known hypersensitivity reaction to any of the proposed therapeutics (see appendix 4) Currently participating in another COVID-19 therapeutic or vaccine trial  Evidence of pneumonia (although imaging is NOT required)  healthy women on the oral contraceptive pill are eligible to join the study